Time-resolved transcriptomic profiling of the developing rabbit's lungs: impact of premature birth and implications for modelling bronchopulmonary dysplasia.
Bronchopulmonary dysplasia
Lung development
Premature birth
Proteomics
Transcriptomics
Journal
Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633
Informations de publication
Date de publication:
15 Mar 2023
15 Mar 2023
Historique:
received:
11
12
2022
accepted:
03
03
2023
entrez:
16
3
2023
pubmed:
17
3
2023
medline:
21
3
2023
Statut:
epublish
Résumé
Premature birth, perinatal inflammation, and life-saving therapies such as postnatal oxygen and mechanical ventilation are strongly associated with the development of bronchopulmonary dysplasia (BPD); these risk factors, alone or combined, cause lung inflammation and alter programmed molecular patterns of normal lung development. The current knowledge on the molecular regulation of lung development mainly derives from mechanistic studies conducted in newborn rodents exposed to postnatal hyperoxia, which have been proven useful but have some limitations. Here, we used the rabbit model of BPD as a cost-effective alternative model that mirrors human lung development and, in addition, enables investigating the impact of premature birth per se on the pathophysiology of BPD without further perinatal insults (e.g., hyperoxia, LPS-induced inflammation). First, we characterized the rabbit's normal lung development along the distinct stages (i.e., pseudoglandular, canalicular, saccular, and alveolar phases) using histological, transcriptomic and proteomic analyses. Then, the impact of premature birth was investigated, comparing the sequential transcriptomic profiles of preterm rabbits obtained at different time intervals during their first week of postnatal life with those from age-matched term pups. Histological findings showed stage-specific morphological features of the developing rabbit's lung and validated the selected time intervals for the transcriptomic profiling. Cell cycle and embryo development, oxidative phosphorylation, and WNT signaling, among others, showed high gene expression in the pseudoglandular phase. Autophagy, epithelial morphogenesis, response to transforming growth factor β, angiogenesis, epithelium/endothelial cells development, and epithelium/endothelial cells migration pathways appeared upregulated from the 28th day of gestation (early saccular phase), which represents the starting point of the premature rabbit model. Premature birth caused a significant dysregulation of the inflammatory response. TNF-responsive, NF-κB regulated genes were significantly upregulated at premature delivery and triggered downstream inflammatory pathways such as leukocyte activation and cytokine signaling, which persisted upregulated during the first week of life. Preterm birth also dysregulated relevant pathways for normal lung development, such as blood vessel morphogenesis and epithelial-mesenchymal transition. These findings establish the 28-day gestation premature rabbit as a suitable model for mechanistic and pharmacological studies in the context of BPD.
Sections du résumé
BACKGROUND
BACKGROUND
Premature birth, perinatal inflammation, and life-saving therapies such as postnatal oxygen and mechanical ventilation are strongly associated with the development of bronchopulmonary dysplasia (BPD); these risk factors, alone or combined, cause lung inflammation and alter programmed molecular patterns of normal lung development. The current knowledge on the molecular regulation of lung development mainly derives from mechanistic studies conducted in newborn rodents exposed to postnatal hyperoxia, which have been proven useful but have some limitations.
METHODS
METHODS
Here, we used the rabbit model of BPD as a cost-effective alternative model that mirrors human lung development and, in addition, enables investigating the impact of premature birth per se on the pathophysiology of BPD without further perinatal insults (e.g., hyperoxia, LPS-induced inflammation). First, we characterized the rabbit's normal lung development along the distinct stages (i.e., pseudoglandular, canalicular, saccular, and alveolar phases) using histological, transcriptomic and proteomic analyses. Then, the impact of premature birth was investigated, comparing the sequential transcriptomic profiles of preterm rabbits obtained at different time intervals during their first week of postnatal life with those from age-matched term pups.
RESULTS
RESULTS
Histological findings showed stage-specific morphological features of the developing rabbit's lung and validated the selected time intervals for the transcriptomic profiling. Cell cycle and embryo development, oxidative phosphorylation, and WNT signaling, among others, showed high gene expression in the pseudoglandular phase. Autophagy, epithelial morphogenesis, response to transforming growth factor β, angiogenesis, epithelium/endothelial cells development, and epithelium/endothelial cells migration pathways appeared upregulated from the 28th day of gestation (early saccular phase), which represents the starting point of the premature rabbit model. Premature birth caused a significant dysregulation of the inflammatory response. TNF-responsive, NF-κB regulated genes were significantly upregulated at premature delivery and triggered downstream inflammatory pathways such as leukocyte activation and cytokine signaling, which persisted upregulated during the first week of life. Preterm birth also dysregulated relevant pathways for normal lung development, such as blood vessel morphogenesis and epithelial-mesenchymal transition.
CONCLUSION
CONCLUSIONS
These findings establish the 28-day gestation premature rabbit as a suitable model for mechanistic and pharmacological studies in the context of BPD.
Identifiants
pubmed: 36922832
doi: 10.1186/s12931-023-02380-y
pii: 10.1186/s12931-023-02380-y
pmc: PMC10015812
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
80Informations de copyright
© 2023. The Author(s).
Références
Am J Physiol Lung Cell Mol Physiol. 2015 May 15;308(10):L983-L1001
pubmed: 25770179
J Biol Chem. 2005 Apr 8;280(14):13809-16
pubmed: 15668254
Am J Respir Cell Mol Biol. 2015 Mar;52(3):263-84
pubmed: 25303647
Genes (Basel). 2018 Sep 05;9(9):
pubmed: 30189656
Pediatr Res. 2017 Feb;81(2):369-375
pubmed: 27973472
Int J Mol Sci. 2016 Oct 24;17(10):
pubmed: 27783043
Pediatr Res. 2017 Jan;81(1-2):210-213
pubmed: 27682969
Am J Pathol. 2016 Apr;186(4):777-93
pubmed: 26878215
Ann Am Thorac Soc. 2015 May;12(5):765-74
pubmed: 25742123
Curr Top Dev Biol. 2010;90:73-158
pubmed: 20691848
Bioessays. 2020 Jun;42(6):e2000006
pubmed: 32310312
Respir Res. 2020 Feb 21;21(1):59
pubmed: 32085773
Am J Physiol Lung Cell Mol Physiol. 2019 Apr 1;316(4):L589-L597
pubmed: 30675804
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
J Clin Invest. 2019 Jun 4;129(7):2904-2919
pubmed: 31162135
Am J Respir Cell Mol Biol. 2021 Mar;64(3):318-330
pubmed: 33264084
Methods Mol Biol. 2018;1841:3-10
pubmed: 30259475
PeerJ. 2016 Aug 09;4:e2318
pubmed: 27602285
Am J Perinatol. 2008 Sep;25(8):473-80
pubmed: 18773379
Histol Histopathol. 2010 Sep;25(9):1105-16
pubmed: 20607652
Am J Physiol Lung Cell Mol Physiol. 2014 Dec 15;307(12):L948-58
pubmed: 25305248
J Clin Invest. 2012 Aug;122(8):2724-30
pubmed: 22850882
Am J Physiol Lung Cell Mol Physiol. 2020 Dec 1;319(6):L949-L956
pubmed: 32903026
Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L1031-41
pubmed: 19304912
Pediatr Pulmonol. 2021 Feb;56(2):392-399
pubmed: 33118673
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Pediatr Res. 2015 May;77(5):608-14
pubmed: 25671807
J Transl Med. 2016 Aug 27;14(1):247
pubmed: 27567616
Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9
pubmed: 11401896
Arch Dis Child. 1960 Dec;35:544-7
pubmed: 13726619
Pediatr Res. 2017 Dec;82(6):1056-1063
pubmed: 28723887
Curr Opin Pediatr. 2014 Jun;26(3):306-14
pubmed: 24739494
Am J Physiol Lung Cell Mol Physiol. 2018 Jul 1;315(1):L11-L24
pubmed: 29516783
Thorax. 1982 Aug;37(8):580-3
pubmed: 7179186
Pharmaceutics. 2022 Jul 20;14(7):
pubmed: 35890402
Chest. 2004 Feb;125(2):754-65
pubmed: 14769761
Front Genet. 2020 Sep 09;11:539292
pubmed: 33033495
Am J Physiol Lung Cell Mol Physiol. 2014 Dec 15;307(12):L970-7
pubmed: 25281639
Matrix Biol. 2018 Nov;73:6-20
pubmed: 29331337
J Cell Biochem. 2020 Jun;121(5-6):3173-3184
pubmed: 31886571
Am J Respir Cell Mol Biol. 2009 May;40(5):555-67
pubmed: 18952566
Mol Biosyst. 2016 Apr;12(4):1342-9
pubmed: 26923754
Neonatology. 2019;115(4):432-450
pubmed: 30974433
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Clin Perinatol. 2019 Sep;46(3):553-565
pubmed: 31345546
PLoS One. 2012;7(8):e37046
pubmed: 22916088
Curr Pharm Des. 2017;23(38):5887-5901
pubmed: 28950821
Mol Cell Proteomics. 2017 May;16(5):873-890
pubmed: 28325852
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Pediatr Res. 2020 Jun;87(7):1193-1200
pubmed: 31816623
Nat Commun. 2021 Mar 10;12(1):1565
pubmed: 33692365
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Data Brief. 2018 Nov 03;22:365-372
pubmed: 30596133
Pediatr Pulmonol. 2006 Jun;41(6):558-69
pubmed: 16617452
Birth Defects Res A Clin Mol Teratol. 2014 Mar;100(3):202-16
pubmed: 24639404
J Cell Biol. 2017 Oct 2;216(10):3369-3385
pubmed: 28838957
Nat Rev Dis Primers. 2019 Nov 14;5(1):78
pubmed: 31727986
Am J Physiol Lung Cell Mol Physiol. 2014 Dec 15;307(12):L936-47
pubmed: 25305249
J Biol Chem. 2006 Mar 31;281(13):8724-31
pubmed: 16377626